Litcius/Paper detail

Immunoprofiling reveals cell subsets associated with the trajectory of cytomegalovirus reactivation post stem cell transplantation

Lauren Stern, Helen M. McGuire, Selmir Avdic, Barbara Fazekas de St Groth, David Gottlieb, Allison Abendroth, Emily Blyth, Barry Slobedman

2022Nature Communications20 citationsDOIOpen Access PDF

Abstract

Abstract Human cytomegalovirus reactivation is a major opportunistic infection after allogeneic haematopoietic stem cell transplantation and has a complex relationship with post-transplant immune reconstitution. Here, we use mass cytometry to define patterns of innate and adaptive immune cell reconstitution at key phases of human cytomegalovirus reactivation in the first 100 days post haematopoietic stem cell transplantation. Human cytomegalovirus reactivation is associated with the development of activated, memory T-cell profiles, with faster effector-memory CD4 + T-cell recovery in patients with low-level versus high-level human cytomegalovirus DNAemia. Mucosal-associated invariant T cell levels at the initial detection of human cytomegalovirus DNAemia are significantly lower in patients who subsequently develop high-level versus low-level human cytomegalovirus reactivation. Our data describe distinct immune signatures that emerged with human cytomegalovirus reactivation after haematopoietic stem cell transplantation, and highlight Mucosal-associated invariant T cell levels at the first detection of reactivation as a marker that may be useful to anticipate the magnitude of human cytomegalovirus DNAemia.

Topics & Concepts

Human cytomegalovirusCytomegalovirusTransplantationStem cellImmune systemBiologyImmunologyHematopoietic stem cell transplantationHaematopoiesisT cellVirologyHerpesviridaeVirusMedicineViral diseaseCell biologyInternal medicineCytomegalovirus and herpesvirus researchImmune Cell Function and InteractionHematopoietic Stem Cell Transplantation
Immunoprofiling reveals cell subsets associated with the trajectory of cytomegalovirus reactivation post stem cell transplantation | Litcius